Armetheon

About:

Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company.

Twitter/X: armetheon

Top Investors: CDIB Capital, Capital TEN, Hercules Bioventure Partners, Atheneos Ventures, AshHill Biomedical

Description:

Armetheon, Inc., is a privately held San Francisco Bay area based clinical stage biopharmaceutical company focused on the development of novel drugs for highly unmet need. The company has several programs in clinical stage of development. These include:

Total Funding Amount:

$31.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2011-01-01

Contact Email:

hlake(AT)armetheon.com

Founders:

Ken Kengatharan, Pascal Druzgala, Peter Milner

Number of Employees:

11-50

Last Funding Date:

2015-02-05

IPO Status:

Private

Industries: